Drug-implantable cardioverter-defibrillator interactions.
Antiarrhythmic drugs are commonly used synergistically with implantable cardioverter defibrillators in the management of ventricular and supraventricular arrhythmias. However, these drugs may directly or indirectly interact with device function. In addition, expanding indications for implantable cardioverter defibrillators, particularly in patients with multiple comorbidities, further increases the potential for drug-device interactions. These potential drug-device interactions are summarized in this article.
Beadle
Roger
R
School of Medicine and Dentistry, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, Scotland AB25 2ZD, UK. rogerbeadle@hotmail.com
Williams
Lynne
L
Lim
Hoong Sern
HS
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003131:Combined Modality Therapy; D017147:Defibrillators, Implantable; D006801:Humans
D000889:Anti-Arrhythmia Agents